Fair Value Measurements - Contingent Consideration (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2021 |
Oct. 06, 2021 |
Dec. 31, 2020 |
Feb. 25, 2019 |
|
| Fair Value Measurements | ||||
| Contingent consideration under RPAs and CPPAs | $ 8,075 | $ 75 | ||
| Bioasis | Royalty Purchase Agreement | ||||
| Fair Value Measurements | ||||
| Changes in estimated fair value of contingent consideration | 0 | |||
| Contingent consideration under RPAs and CPPAs | 100 | $ 100 | ||
| Affitech | Royalty Purchase Agreement | ||||
| Fair Value Measurements | ||||
| Changes in estimated fair value of contingent consideration | 0 | |||
| Contingent consideration under RPAs and CPPAs | $ 8,000 | $ 8,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Contingent consideration under purchase agreements. May include royalty purchase agreements and commercial payment purchase agreements. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|